Clinical Trials
Children’s Hospital New Orleans Clinical Trials Center
Innovating medicine & treatment for pediatric services
The Clinical Trials Center™ (CTC) was established in 1999 to improve
healthcare for children and adolescents through the development of new
medications and treatments. Our efforts help to create a culture in which
safer and more effective drugs and treatments are available for a wide
range of health problems. The Clinical Trials Center™ organizes
community and hospital-based physicians into a multispecialty research
network. The CTC is located at the main campus of Children’s Hospital.
Active clinical trials at Children's Hospital
Sickle Cell Disease Study
The Clinical Trials Center at Children’s Hospital is participating in The Hibiscus Study™. This trial is evaluating the safety and effectiveness of an investigational medication compared with placebo (inactive drug) in people 12 to 65 years of age with sickle cell disease. The study is evaluating if the investigational medication, etavopivat, can improve anemia and reduce the number of pain crises per year.
Learn more about the Hibiscus Study™
Urology Study for Adolescents with Neurogenic Detrusor Overactivity
The Clinical Trial center at Children’s Hospital is participating in the Kanguroo Study for pediatric patients with neurogenic detrusor overactivity who are on clean intermittent catheterizations. In this study, participants will take a study drug called vibegron, a drug that relaxes the muscle involved in normal bladder function and is usually used to treat overactive bladder in adults. The study will measure the safety and effectiveness of vibegron when used in children aged 12-17 years.
Learn more about the Kanguroo Study
To learn more or enroll in a clinical trial, call the Children's Hospital Clinical Trial Center at 504.894.5377.
